Every US product recall. One feed.

Data refreshed August 4, 2026 · last 180 days

467recalls · last 30 days
43CPSC · last 30 days
353FDA · last 30 days
66NHTSA · last 30 days
5FSIS · last 30 days
3,513in 180-day window

Rising Pharma Holding, Inc. recalls

RecallSweep is tracking 2 recall notices naming Rising Pharma Holding, Inc. in the last 180 days, issued by FDA. The most recent is dated July 29, 2026 and the oldest in this window March 11, 2026. They cover Drugs & Supplements.

This page lists what the issuing agencies published. It is not a statement about Rising Pharma Holding, Inc. beyond those notices — open each official notice for the authoritative detail.

Recall notices naming Rising Pharma Holding, Inc.

2 recalls.

FDA Class II Drugs & Supplements

Rising Pharma Holding, Inc.: Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc.,…

Affected quantity: 74208 units

Hazard
Presence of Precipitate: medication was crystallizing and particles floating in the bottle

Details
Distribution: Nationwide U.S.A.. Recall #D-0724-2026, initiated 20260713. Voluntary: Firm initiated.

Products affected
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.

Recall status
Ongoing

Look up recall #D-0724-2026 in the FDA enforcement database ↗
FDA Class II Drugs & Supplements

Rising Pharma Holding, Inc.: Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc.,…

Affected quantity: 1200 bottles

Hazard
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

Details
Distribution: Nationwide within the U.S. Recall #D-0384-2026, initiated 20260303. Voluntary: Firm initiated.

Products affected
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.

Recall status
Ongoing

Look up recall #D-0384-2026 in the FDA enforcement database ↗

Categories

Agencies

Other brands recalled in the same categories

Browse